Overview of Dr. Rosen
Dr. Ezra Rosen is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 9 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 20 publications and over 500 citings.
Office
300 East 66th Street
Floors 1 - 4
New York, NY 10065
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2013 - 2016
David Geffen School of Medicine at UCLAClass of 2013
Certifications & Licensure
FL State Medical License 2022 - Present
NJ State Medical License 2020 - 2025
NY State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy.Victor Ng, Sonali Sinha, Ardijana Novaj, Jennifer Ma, Niamh McDermott
Clinical Cancer Research. 2024-12-16 - Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets.Monica F Chen, Soo-Ryum Yang, Jessica J Tao, Antoine Desilets, Eli L Diamond
Clinical Cancer Research. 2024-09-03 - 2 citationsAtaxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).Elisa Fontana, Ezra Rosen, Elizabeth K Lee, Martin Højgaard, Niharika B Mettu
Journal of the National Cancer Institute. 2024-09-01
Press Mentions
eFFECTOR to Present Updated Clinical Data from Phase 2 Expansion Cohorts for Zotatifin in Patients with ER+ Metastatic Breast Cancer at ASCO 2023 Annual MeetingApril 26th, 2023- SpringWorks Therapeutics Announces Phase 1b/2a Clinical Trial of Mirdametinib in Patients with Advanced Solid Cancers Harboring MAPK-Activating MutationsAugust 3rd, 2021
- Zotatifin Triplet May Improve Outcomes Post–CDK4/6 Inhibition in ER+ Breast CancerOctober 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
